BIOCON option chain
IV vs HV, IV percentile & PCR history →End of day 02 Nov 2026 · expiry 25 Jan 2027 (84 days) · lot 2500
Spot
354.69
Future
359.00
Forward
359.00
PCR (OI)
—
Puts — / Calls —
PCR (volume)
—
Puts — / Calls —
Max pain
—
strike with least total payout to holders
Highest OI
— CE · — PE
ΔOI calls +— · puts +—
Open interest by strike
CallsPuts│ ATM
| Calls | Puts | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buildup | OI | ΔOI | IV % | Chg | LTP | Strike | LTP | Chg | IV % | ΔOI | OI | Buildup | ||||||
| Neutral | — | — | 29.93 | 0.00 | 44.20 | 300 | 7.10 | 0.00 | 27.87 | — | — | Neutral | ||||||
| Neutral | — | — | 29.34 | 0.00 | 37.25 | 310 | 10.00 | 0.00 | 27.86 | — | — | Neutral | ||||||
| Neutral | — | — | 28.96 | 0.00 | 31.00 | 320 | 13.60 | 0.00 | 27.85 | — | — | Neutral | ||||||
| Neutral | — | — | 28.72 | 0.00 | 25.50 | 330 | 17.95 | 0.00 | 27.82 | — | — | Neutral | ||||||
| Neutral | — | — | 28.56 | 0.00 | 20.70 | 340 | 23.00 | 0.00 | 27.81 | — | — | Neutral | ||||||
| Neutral | — | — | 28.45 | 0.00 | 16.60 | 350 | 28.75 | 0.00 | 27.77 | — | — | Neutral | ||||||
| Neutral | — | — | 28.35 | 0.00 | 13.15 | 360 | 35.15 | 0.00 | 27.75 | — | — | Neutral | ||||||
| Neutral | — | — | 28.30 | 0.00 | 10.30 | 370 | 42.15 | 0.00 | 27.72 | — | — | Neutral | ||||||
| Neutral | — | — | 28.24 | 0.00 | 8.00 | 380 | 49.70 | 0.00 | 27.69 | — | — | Neutral | ||||||
| Neutral | — | — | 28.22 | 0.00 | 6.15 | 390 | 57.65 | 0.00 | 27.64 | — | — | Neutral | ||||||
| Neutral | — | — | 28.19 | 0.00 | 4.65 | 400 | 66.05 | 0.00 | 27.59 | — | — | Neutral | ||||||
| Neutral | — | — | 28.14 | 0.00 | 2.60 | 420 | 83.70 | 0.00 | 27.43 | — | — | Neutral | ||||||
Source: NSE F&O bhavcopy (EOD, official). Black-76 on the forward; IV from close (settle if untraded). Forward: same-expiry future. Discounting at 6.83% (carry implied by 23 Nov → 29 Dec futures). Buildup labels describe price and open-interest changes only and are not advice. Spot: NSE F&O bhavcopy underlying price.